{"unnormalised": "AIIMS Delhi recently announced a breakthrough in cancer treatment. A clinical trial using a new immunotherapy drug, coded as “ONC201,” showed promising results in patients with advanced-stage melanoma. The trial, which began on 01/01/2023 and concluded on 30/06/2024, involved 50 patients.", "normalised": "A-I-I-M-S Delhi recently announced a breakthrough in cancer treatment. A clinical trial using a new immunotherapy drug, coded as “O-N-C two zero one,” showed promising results in patients with advanced-stage melanoma. The trial, which began on first January two thousand and twenty three and concluded on thirtieth June two thousand and twenty four, involved fifty patients."}
{"unnormalised": "The study indicated that ONC201, administered at a dosage of 50mg, significantly reduced tumor size in 40% of the participants. Dr. Rajesh Kumar, the lead oncologist, stated that the drug targets the cancer cells with greater precision, minimizing side effects. Patients experienced manageable symptoms such as fatigue and mild nausea, unlike the more severe side effects associated with traditional chemotherapy. The research team plans to publish their full findings in the Lancet Oncology by 15/08/2024.", "normalised": "The study indicated that O-N-C two zero one, administered at a dosage of fifty milligram, significantly reduced tumor size in forty percent of the participants. Doctor Rajesh Kumar, the lead oncologist, stated that the drug targets the cancer cells with greater precision, minimizing side effects. Patients experienced manageable symptoms such as fatigue and mild nausea, unlike the more severe side effects associated with traditional chemotherapy. The research team plans to publish their full findings in the Lancet Oncology by fifteenth August two thousand and twenty four."}
{"unnormalised": "Further research is now focused on applying ONC201 to other types of cancer, including breast cancer and lung cancer. AIIMS is seeking funding of Rs. 2 crore to expand the research program. Experts believe this development could represent a major step forward in making cancer treatment more effective and accessible in India.", "normalised": "Further research is now focused on applying O-N-C two zero one to other types of cancer, including breast cancer and lung cancer. A-I-I-M-S is seeking funding of rupee two crore to expand the research program. Experts believe this development could represent a major step forward in making cancer treatment more effective and accessible in India."}
